108 related articles for article (PubMed ID: 23684659)
1. Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-β-cyclodextrin.
Onodera R; Motoyama K; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
Int J Pharm; 2013 Aug; 452(1-2):116-23. PubMed ID: 23684659
[TBL] [Abstract][Full Text] [Related]
2. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts.
Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086
[TBL] [Abstract][Full Text] [Related]
4. [Development of Cyclodextrin-based Cancer Treatment].
Motoyama K
Yakugaku Zasshi; 2015; 135(11):1291-8. PubMed ID: 26521878
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H
Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918
[TBL] [Abstract][Full Text] [Related]
6. Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent.
Onodera R; Motoyama K; Okamatsu A; Higashi T; Arima H
Sci Rep; 2013; 3():1104. PubMed ID: 23346361
[TBL] [Abstract][Full Text] [Related]
7. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
[TBL] [Abstract][Full Text] [Related]
8. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
[TBL] [Abstract][Full Text] [Related]
9. Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated beta-cyclodextrins.
Motoyama K; Toyodome H; Onodera R; Irie T; Hirayama F; Uekama K; Arima H
Biol Pharm Bull; 2009 Apr; 32(4):700-5. PubMed ID: 19336908
[TBL] [Abstract][Full Text] [Related]
10. 2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.
Yokoo M; Kubota Y; Motoyama K; Higashi T; Taniyoshi M; Tokumaru H; Nishiyama R; Tabe Y; Mochinaga S; Sato A; Sueoka-Aragane N; Sueoka E; Arima H; Irie T; Kimura S
PLoS One; 2015; 10(11):e0141946. PubMed ID: 26535909
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
Li YC; Park MJ; Ye SK; Kim CW; Kim YN
Am J Pathol; 2006 Apr; 168(4):1107-18; quiz 1404-5. PubMed ID: 16565487
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
[TBL] [Abstract][Full Text] [Related]
13. Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin.
Onodera R; Motoyama K; Tanaka N; Ohyama A; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
Sci Rep; 2014 Mar; 4():4417. PubMed ID: 24646866
[TBL] [Abstract][Full Text] [Related]
14. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of cell death in head and neck cell carcinoma through alteration of cholesterol levels in lipid rafts microdomains.
Bionda C; Athias A; Poncet D; Alphonse G; Guezguez A; Gambert P; Rodriguez-Lafrasse C; Ardail D
Biochem Pharmacol; 2008 Feb; 75(3):761-72. PubMed ID: 17996216
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
[TBL] [Abstract][Full Text] [Related]
17. Methyl-β-cyclodextrin induces programmed cell death in chronic myeloid leukemia cells and, combined with imatinib, produces a synergistic downregulation of ERK/SPK1 signaling.
Yan J; Li QF; Wang LS; Wang H; Xiao FJ; Yang YF; Wu CT
Anticancer Drugs; 2012 Jan; 23(1):22-31. PubMed ID: 21857502
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
[TBL] [Abstract][Full Text] [Related]
19. Effects of methyl-beta-cyclodextrin on T lymphocytes lipid rafts with aging.
Larbi A; Douziech N; Khalil A; Dupuis G; Gheraïri S; Guérard KP; Fülöp T
Exp Gerontol; 2004 Apr; 39(4):551-8. PubMed ID: 15050290
[TBL] [Abstract][Full Text] [Related]
20. Methyl-beta-cyclodextrin induces mitochondrial cholesterol depletion and alters the mitochondrial structure and bioenergetics.
Ziolkowski W; Szkatula M; Nurczyk A; Wakabayashi T; Kaczor JJ; Olek RA; Knap N; Antosiewicz J; Wieckowski MR; Wozniak M
FEBS Lett; 2010 Nov; 584(22):4606-10. PubMed ID: 20965172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
